| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Madsen JS et al. | Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women. | 2003 | J. Thromb. Haemost. | pmid:12941041 |
| PerusquÃa M et al. | Vasodilating effect of norethisterone and its 5 alpha metabolites: a novel nongenomic action. | 2003 | Eur. J. Pharmacol. | pmid:12954372 |
| Neven P et al. | A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate. | 2003 | BJOG | pmid:12618160 |
| Jirapinyo M et al. | Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. | 2003 | Acta Obstet Gynecol Scand | pmid:12911449 |
| Li C et al. | Low-dose hormone therapy and carbohydrate metabolism. | 2003 | Fertil. Steril. | pmid:12620438 |
| Boon J et al. | Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT. | 2003 | Maturitas | pmid:12963171 |
| Ylikorkala O et al. | Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women. | 2003 | Fertil. Steril. | pmid:12969695 |
| Aussenac F et al. | Cholesterol dynamics in membranes of raft composition: a molecular point of view from 2H and 31P solid-state NMR. | 2003 | Biochemistry | pmid:12578350 |
| Skarda J | Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice. | 2003 | J Vet Med A Physiol Pathol Clin Med | pmid:12948158 |
| Reddy LV et al. | Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. | 2003 | Neuron | pmid:14642280 |
| Boyd RA et al. | The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy. | 2003 | J Clin Pharmacol | pmid:12520628 |
| Barth A et al. | Influence of ethinyloestradiol propanolsulphonate on serum bile acids in healthy volunteers. | 2003 | Exp. Toxicol. Pathol. | pmid:12877349 |
| Görög S | Chemical and analytical characterization of related organic impurities in drugs. | 2003 | Anal Bioanal Chem | pmid:12937879 |
| Walker AE et al. | PRIME--PRocess modelling in ImpleMEntation research: selecting a theoretical basis for interventions to change clinical practice. | 2003 | BMC Health Serv Res | pmid:14683530 |
| Nagaoka S et al. | The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. | 2003 | Cancer | pmid:14669288 |
| de Gooyer ME et al. | Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. | 2003 | Steroids | pmid:12628686 |
| Sidelmann JJ et al. | Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study. | 2003 | BJOG | pmid:12798469 |
| Fenkci V et al. | The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study. | 2003 | Gynecol. Obstet. Invest. | pmid:12865592 |
| Arabi A et al. | Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. | 2003 | Hum. Reprod. | pmid:12871894 |
| Gambacciani M et al. | Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. | 2003 | Maturitas | pmid:12590012 |
| Portman DJ et al. | A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone. | 2003 | Am. J. Obstet. Gynecol. | pmid:12592236 |
| Simon JA et al. | Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. | 2003 | Am. J. Obstet. Gynecol. | pmid:12548201 |
| Gorgulu S et al. | The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function. | 2003 | Acta Cardiol | pmid:12625488 |
| Zouboulis CC and Piquero-Martin J | Update and future of systemic acne treatment. | 2003 | Dermatology (Basel) | pmid:12566804 |
| Biglia N et al. | Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens. | 2003 | Maturitas | pmid:12927315 |
| Doose DR et al. | Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. | 2003 | Epilepsia | pmid:12681003 |
| Cano A et al. | The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women. | 2003 | Arch. Gynecol. Obstet. | pmid:14504877 |
| McKenzie J et al. | Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? | 2003 | Clin. Endocrinol. (Oxf) | pmid:14974908 |
| Nugent AG et al. | Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. | 2003 | Clin. Endocrinol. (Oxf) | pmid:14974909 |
| Buckler H and Al-Azzawi F | The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women. | 2003 | BJOG | pmid:12892687 |
| Stahlberg C et al. | Hormone replacement therapy and risk of breast cancer: the role of progestins. | 2003 | Acta Obstet Gynecol Scand | pmid:12790856 |
| Illouz S et al. | Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance. | 2003 | Int. J. Mol. Med. | pmid:12964029 |
| Muneyyirci-Delale O et al. | Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate? | 2003 Jan-Feb | Int J Fertil Womens Med | pmid:12643518 |
| Rubinacci A et al. | Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. | 2003 May-Jun | Menopause | pmid:12792297 |
| Roberts LM et al. | Extraperitoneal endometriosis with catamenial pneumothoraces: a review of the literature. | 2003 Oct-Dec | JSLS | pmid:14626406 |
| Barr Laboratories recalls Nortrel contraceptive. | 2003 Sep-Oct | FDA Consum | pmid:14666892 | |
| Grinspoon S et al. | Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15292338 |
| Odmark IS et al. | Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens. | 2004 | Climacteric | pmid:15259288 |
| Clark RA and Theall K | Population-based study evaluating association between selected antiretroviral therapies and potential oral contraceptive failure. | 2004 | J. Acquir. Immune Defic. Syndr. | pmid:15319685 |
| Watanabe K et al. | Effects of progesterone and norethisterone on cephalexin uptake in the human intestinal cell line Caco-2. | 2004 | Biol. Pharm. Bull. | pmid:15056866 |
| Cagnacci A et al. | A comparison of the central effects of different progestins used in hormone replacement therapy. | 2004 | Maturitas | pmid:15283939 |
| Lazar F et al. | Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users. | 2004 | Maturitas | pmid:15283941 |
| Hapgood JP et al. | Not all progestins are the same: implications for usage. | 2004 | Trends Pharmacol. Sci. | pmid:15491776 |
| Bain CA et al. | The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women. | 2004 | Hum. Reprod. | pmid:15284214 |
| Yu Z et al. | Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive. | 2004 | Clin Pharmacokinet | pmid:15244497 |
| Crisafulli A et al. | Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. | 2004 | J. Clin. Endocrinol. Metab. | pmid:14715848 |
| Pedersen NG et al. | Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits. | 2004 | Maturitas | pmid:15531126 |
| Piccioni P et al. | Hormonal replacement therapy after stem cell transplantation. | 2004 | Maturitas | pmid:15531129 |
| Berenson AB et al. | Effects of hormonal contraception on bone mineral density after 24 months of use. | 2004 | Obstet Gynecol | pmid:15121563 |
| Higa A et al. | Vitreous haemorrhage in a 19-year-old Japanese woman using an oral contraceptive. | 2004 | Acta Ophthalmol Scand | pmid:15043555 |
| Kidwai N et al. | Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. | 2004 | Breast Cancer Res. | pmid:14680496 |
| Tonetti DA | Prevention of breast cancer by recapitulation of pregnancy hormone levels. | 2004 | Breast Cancer Res. | pmid:14680493 |
| Kim WY and Benet LZ | P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. | 2004 | Pharm. Res. | pmid:15290871 |
| Stevenson JC et al. | Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. | 2004 | Br. J. Haematol. | pmid:15009069 |
| Canto de Cetina TE et al. | Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections. | 2004 | Contraception | pmid:14759615 |
| Webb A et al. | Effect of hormonal emergency contraception on bleeding patterns. | 2004 | Contraception | pmid:14759618 |
| Kernohan AF et al. | Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes. | 2004 | Diab Vasc Dis Res | pmid:16302646 |
| Beckman M | Wayward sisters. Progestin siblings exert opposite effects on monkey hearts. | 2004 | Sci Aging Knowledge Environ | pmid:15483332 |
| Gravholt CH et al. | The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. | 2004 | Eur. J. Endocrinol. | pmid:15012622 |
| Dahmoun M et al. | Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT. | 2004 | Maturitas | pmid:15474755 |
| Mirkin S and Archer DF | Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17beta-estradiol on thrombospondin-1 mRNA in Ishikawa cells. | 2004 | Fertil. Steril. | pmid:15237017 |
| Weingertner AS et al. | [Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties]. | 2004 | J Gynecol Obstet Biol Reprod (Paris) | pmid:15687940 |
| Latsch S et al. | Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems. | 2004 | Eur J Pharm Biopharm | pmid:15019001 |
| Nunes FM et al. | The use of Open Reading frame ESTs (ORESTES) for analysis of the honey bee transcriptome. | 2004 | BMC Genomics | pmid:15527499 |
| Perrone JA et al. | Weight loss dynamics during combined fluoxetine and olanzapine treatment. | 2004 | BMC Pharmacol. | pmid:15498104 |
| Tedone L et al. | Long-distance transport of L-ascorbic acid in potato. | 2004 | BMC Plant Biol. | pmid:15377389 |
| Høegh-Andersen P et al. | Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. | 2004 | Arthritis Res. Ther. | pmid:15059281 |
| Mullin N et al. | Coil or intrauterine device? Patient preferences for contraceptive terminology. | 2004 | J Fam Plann Reprod Health Care | pmid:15006314 |
| Garcea G et al. | Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. | 2004 | Br. J. Cancer | pmid:14997198 |
| Csizmadi I et al. | The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women. | 2004 | Br. J. Cancer | pmid:14710210 |
| Odmark IS et al. | Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins. | 2004 | Maturitas | pmid:15172088 |
| Fröhlich M et al. | In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins. | 2004 | Biochem. Pharmacol. | pmid:15548387 |
| Czarnecka D et al. | The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. | 2004 | Med. Sci. Monit. | pmid:14737044 |
| GarcÃa-Becerra R et al. | Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins. | 2004 | J. Steroid Biochem. Mol. Biol. | pmid:15261304 |
| Hendrix CW et al. | The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. | 2004 | Clin. Pharmacol. Ther. | pmid:15116059 |
| Cagnacci A et al. | Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels. | 2004 | Fertil. Steril. | pmid:14711550 |
| Graff-Iversen S et al. | Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women. | 2004 | J. Intern. Med. | pmid:15485480 |
| Archer DF et al. | Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells. | 2004 | Fertil. Steril. | pmid:14711561 |
| Norethisterone. | 2004 | Rep Carcinog | pmid:21105253 | |
| Conner P et al. | Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy. | 2004 | Fertil. Steril. | pmid:15193485 |
| Faludi AA et al. | Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. | 2004 | Atherosclerosis | pmid:15488870 |
| Faassen F and Vromans H | Biowaivers for oral immediate-release products: implications of linear pharmacokinetics. | 2004 | Clin Pharmacokinet | pmid:15568890 |
| Rajkumar L et al. | Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. | 2004 | Breast Cancer Res. | pmid:14680498 |
| Kwok S et al. | Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy. | 2004 | Clin. Endocrinol. (Oxf) | pmid:15579192 |
| Hugues JN | [The programming of IVF cycles with antagonists]. | 2004 | J Gynecol Obstet Biol Reprod (Paris) | pmid:15643680 |
| Madauss KP et al. | Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes. | 2004 | J. Med. Chem. | pmid:15189034 |
| Neven P et al. | Uterine effects of estrogen plus progestin therapy and raloxifene: adjudicated results from the EURALOX study. | 2004 | Obstet Gynecol | pmid:15121561 |
| Griffith SG and Dai Y | Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. | 2004 | Clin Ther | pmid:15823769 |
| Latsch S et al. | Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy. | 2004 | Eur J Pharm Biopharm | pmid:15019000 |
| Shochet T et al. | Side effects of the Yuzpe regimen of emergency contraception and two modifications. | 2004 | Contraception | pmid:15033405 |
| Scott AR et al. | Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. | 2004 | Diabetes Obes Metab | pmid:14686958 |
| Ailawadi RK et al. | Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. | 2004 | Fertil. Steril. | pmid:14967362 |
| Alhenc-Gelas M et al. | Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives. | 2004 | J. Thromb. Haemost. | pmid:15333036 |
| Afsar NA et al. | Use of norethisterone oenanthate and predisposition to thrombosis. | 2004 | J Coll Physicians Surg Pak | pmid:15353142 |
| Horn LC et al. | Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. | 2004 Mar-Apr | Int. J. Gynecol. Cancer | pmid:15086736 |
| First chewable oral contraceptive. | 2004 Mar-Apr | FDA Consum | pmid:15101351 | |
| Christodoulakos GE et al. | The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women. | 2004 May-Jun | Menopause | pmid:15167309 |
| Botteman MF et al. | A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms. | 2004 May-Jun | Menopause | pmid:15167315 |
| Wasnich RD et al. | Changes in bone density and turnover after alendronate or estrogen withdrawal. | 2004 Nov-Dec | Menopause | pmid:15545790 |
| Shakir YA et al. | Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women's Health in the Lund Area study. | 2004 Sep-Oct | Menopause | pmid:15356408 |